The split thickness skin graft donor site; A comparative study of Tegaderm Absorbent and Kaltostat Alginate dressings

The split thickness skin graft donor site; A prospective randomised controlled trial that demonstrates improved rates of healing, reduced pain and superior ease of management with Tegaderm Absorbent in comparision to Kaltostat aliginate dressings.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12607000356460

Enrollment

Registered

2007-07-03

Start date

2006-07-07

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A trial has been carried out comparing a new dressing Tegaderm Absorbent with Kaltostat alginate dressing for use on the skin graft donor site.

Interventions

Comparative study of 2 dressings - Contol dresssing; Kaltostat Alginate . New dressing on trial; Tegaderm Absorbent. . The first donor site dressing assessment is done 10-14 days postoperatively and subsequent dressings are done weekly thereafter till fully healed. Maximum duration 4 weeks / average duration 14 days.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

10 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients requiring a split thickness skin graft to be harvested from their thigh

Exclusion criteria

Patients with allergies to Polyurethrane film dressings or Mefix tape.

Outcome results